[go: up one dir, main page]
More Web Proxy on the site http://driver.im/

ATE487947T1 - Verfahren zur diagnose und behandlung auf nr2- peptiden beruhender zerebrovaskulärer ereignisse - Google Patents

Verfahren zur diagnose und behandlung auf nr2- peptiden beruhender zerebrovaskulärer ereignisse

Info

Publication number
ATE487947T1
ATE487947T1 AT06773062T AT06773062T ATE487947T1 AT E487947 T1 ATE487947 T1 AT E487947T1 AT 06773062 T AT06773062 T AT 06773062T AT 06773062 T AT06773062 T AT 06773062T AT E487947 T1 ATE487947 T1 AT E487947T1
Authority
AT
Austria
Prior art keywords
diagnosing
peptides
cerebrovascular events
treating cerebrovascular
events related
Prior art date
Application number
AT06773062T
Other languages
English (en)
Inventor
Svetlana Dambinova
Original Assignee
Cis Biotech Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Cis Biotech Inc filed Critical Cis Biotech Inc
Application granted granted Critical
Publication of ATE487947T1 publication Critical patent/ATE487947T1/de

Links

Classifications

    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6893Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to diseases not provided for elsewhere
    • G01N33/6896Neurological disorders, e.g. Alzheimer's disease
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/94Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving narcotics or drugs or pharmaceuticals, neurotransmitters or associated receptors
    • G01N33/9406Neurotransmitters
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00Detection or diagnosis of diseases
    • G01N2800/28Neurological disorders
    • G01N2800/2871Cerebrovascular disorders, e.g. stroke, cerebral infarct, cerebral haemorrhage, transient ischemic event

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Molecular Biology (AREA)
  • Chemical & Material Sciences (AREA)
  • Urology & Nephrology (AREA)
  • Hematology (AREA)
  • Immunology (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Analytical Chemistry (AREA)
  • General Physics & Mathematics (AREA)
  • Cell Biology (AREA)
  • Biotechnology (AREA)
  • Food Science & Technology (AREA)
  • Microbiology (AREA)
  • Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Biochemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
AT06773062T 2005-06-13 2006-06-13 Verfahren zur diagnose und behandlung auf nr2- peptiden beruhender zerebrovaskulärer ereignisse ATE487947T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US68980605P 2005-06-13 2005-06-13
PCT/US2006/023020 WO2006135893A2 (en) 2005-06-13 2006-06-13 Methods for diagnosing and treating cerebrovascular events based on nr2 peptides

Publications (1)

Publication Number Publication Date
ATE487947T1 true ATE487947T1 (de) 2010-11-15

Family

ID=37532899

Family Applications (1)

Application Number Title Priority Date Filing Date
AT06773062T ATE487947T1 (de) 2005-06-13 2006-06-13 Verfahren zur diagnose und behandlung auf nr2- peptiden beruhender zerebrovaskulärer ereignisse

Country Status (9)

Country Link
US (2) US20060281135A1 (de)
EP (1) EP1899726B1 (de)
JP (1) JP2008547002A (de)
CN (1) CN101268370A (de)
AT (1) ATE487947T1 (de)
CA (1) CA2610833A1 (de)
DE (1) DE602006018145D1 (de)
RU (1) RU2008101419A (de)
WO (1) WO2006135893A2 (de)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6896872B2 (en) 2001-06-27 2005-05-24 Svetlana A. Dambinova Rapid multiple panel of biomarkers in laboratory blood tests for TIA/stroke
US20060257943A1 (en) * 2005-01-25 2006-11-16 Cis Biotech, Inc. Ischemic biomarkers and their use to predict adverse neurological events from surgery
US20080081980A1 (en) * 2006-09-18 2008-04-03 Michael Maschke Apparatus and process for stroke examination and treatment using a C-arch X-ray system
US9958442B2 (en) 2009-02-11 2018-05-01 Duke University Sensors incorporating antibodies and methods of making and using the same
WO2014160431A1 (en) 2013-03-13 2014-10-02 Health Diagnostic Laboratory, Inc. Method of determining prior history of ischemic stroke for current risk evaluation and therapy guidance
WO2015187227A2 (en) 2014-03-13 2015-12-10 Duke University Electronic platform for sensing and control of electrochemical reactions
RU2668534C1 (ru) 2017-07-18 2018-10-01 Общество с ограниченной ответственностью "ДРД" Диагностический набор реагентов для выявления хронических патологий мозга ишемического генеза

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2159106C (en) * 1993-04-20 2009-10-06 Lorrie P. Daggett Human n-methyl-d-aspartate receptor subunits, nucleic acids encoding same and uses therefor
WO2002012892A2 (en) 2000-08-04 2002-02-14 Cis Biotech, Inc. Rapid multiple panel of biomarkers in laboratory blood tests for tia/stroke
US6896872B2 (en) * 2001-06-27 2005-05-24 Svetlana A. Dambinova Rapid multiple panel of biomarkers in laboratory blood tests for TIA/stroke
EP1689288B1 (de) * 2003-11-06 2010-04-21 Grace Laboratories, Inc. Immunsorbens-bluttests zur beurteilung von paroxysmalen zerebralentladungen

Also Published As

Publication number Publication date
DE602006018145D1 (de) 2010-12-23
CN101268370A (zh) 2008-09-17
EP1899726A2 (de) 2008-03-19
EP1899726A4 (de) 2009-02-25
US20060281135A1 (en) 2006-12-14
EP1899726B1 (de) 2010-11-10
CA2610833A1 (en) 2006-12-21
JP2008547002A (ja) 2008-12-25
US20090181006A1 (en) 2009-07-16
WO2006135893A2 (en) 2006-12-21
US8084225B2 (en) 2011-12-27
WO2006135893A3 (en) 2007-03-01
RU2008101419A (ru) 2009-07-20

Similar Documents

Publication Publication Date Title
ATE487947T1 (de) Verfahren zur diagnose und behandlung auf nr2- peptiden beruhender zerebrovaskulärer ereignisse
EA201400491A1 (ru) Сопровождающая диагностика для терапии с антигиалуроновым агентом и способы ее применения
DE602005024639D1 (de) Verfahren und Gerät zur Diagnose des Ermüdungsversagens von Turboladern
EP2041317A4 (de) Mikro-rna-basierte verfahren und zusammensetzungen zur diagnose und behandlung von erkrankungen in zusammenhang mit darmkrebs
ATE493649T1 (de) Verfahren zur diagnose von polyzystischer nierenkrankheit
WO2008146309A3 (en) Genetic variants on chr 5pl2 and 10q26 as markers for use in breast cancer risk assessment, diagnosis, prognosis and treatment
EP2215258A4 (de) Verfahren zur diagnose von tumorerkrankungen
EP2215257A4 (de) Verfahren zur diagnose von tumorerkrankungen
WO2008091814A3 (en) Assessment of asthma and allergen-dependent gene expression
EP2320057A4 (de) Diagnosevorrichtung für kraftstoffsparenden betrieb, diagnosesystem für kraftstoffsparenden betrieb, antriebsaggregatsteuerung, vorrichtung zur auswertung von kraftstoffsparendem betrieb und diagnoseverfahren für kraftstoffsparenden betrieb
EP4293358A3 (de) Flüchtige organische verbindungen als krebs biomarker
MX2009013649A (es) Variantes geneticas en el cromosoma 15q24 como marcadores para usarse en diagnostico, prognosis y tratamiento de sindrome de exfoliacion y glaucoma.
BR112012009846B8 (pt) método in vitro e kit para detecção de um anticorpo antifármaco de isotipo ige, e uso de um anticorpo antifármaco de isotipo ige no tratamento de distúrbio mediado por ige
ATE514948T1 (de) In vitro verfahren zur diagnose von neurodegenerativen erkrankungen
EP1991274A4 (de) Verfahren zur behandlung, prophylaxe und diagnose von knochenerkrankungen
WO2010025414A3 (en) Diagnostics and treatments for vegf-independent tumors
WO2006073682A3 (en) Diagnostic test
DE502006008028D1 (de) Liquordiagnostisches in vitro verfahren zur diagnose von demenz-erkrankungen und neuroinflammatorischen erkrankungen
DE602006014106D1 (de) Verfahren zur diagnose von prostatakrebs
DE602006009786D1 (de) Anwendung von molekülen und verfahren zur behandlung von mit mcp-1/ccr2 assoziierten krankheiten
DE602006013143D1 (de) Verfahren zum nachweis aggregatbildender zirkulierender proteinformen und mittel zum einfangen gebildeter aggregate
EP1851340A4 (de) Verfahren zur diagnose und behandlung von krebs mittels b-catenin-spleissvarianten
ATE525481T1 (de) Verfahren zur diagnose thromboembolischer erkrankungen und koronarer herzerkrankungen
ATE406579T1 (de) Verfahren zur diagnose von tumoren
DE502006005862D1 (de) Filterlage für einen, insbesondere konischen, wabenkörper zur abgasbehandlung und verfahren zur herstellung der filterlage

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties